Cargando…
Potential impact of 5 years of ivermectin mass drug administration on malaria outcomes in high burden countries
INTRODUCTION: The global progress against malaria has slowed significantly since 2017. As the current malaria control tools seem insufficient to get the trend back on track, several clinical trials are investigating ivermectin mass drug administration (iMDA) as a potential additional vector control...
Autores principales: | Marathe, Achla, Shi, Ruoding, Mendez-Lopez, Ana, Hu, Zhihao, Lewis, Bryan, Rabinovich, Regina, Chaccour, Carlos J, Rist, Cassidy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8587489/ https://www.ncbi.nlm.nih.gov/pubmed/34764146 http://dx.doi.org/10.1136/bmjgh-2021-006424 |
Ejemplares similares
-
BOHEMIA: Broad One Health Endectocide-based Malaria Intervention in Africa—a phase III cluster-randomized, open-label, clinical trial to study the safety and efficacy of ivermectin mass drug administration to reduce malaria transmission in two African settings
por: Chaccour, Carlos, et al.
Publicado: (2023) -
Ivermectin to reduce malaria transmission II. Considerations regarding clinical development pathway
por: Chaccour, Carlos, et al.
Publicado: (2017) -
Ivermectin to reduce malaria transmission III. Considerations regarding regulatory and policy pathways
por: Chaccour, Carlos, et al.
Publicado: (2017) -
Ivermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safety
por: Chaccour, Carlos, et al.
Publicado: (2017) -
Ivermectin and COVID-19: Keeping Rigor in Times of Urgency
por: Chaccour, Carlos, et al.
Publicado: (2020)